Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

Gastroenterology - United Kingdom
doi 10.1053/j.gastro.2015.04.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Fecal Microbiota Transplantation Ameliorates Active Ulcerative Colitis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2020English

Ginger in Patients With Active Ulcerative Colitis: A Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2020English

Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

Gastroenterology
HepatologyGastroenterology
2019English

Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis

Gastroenterology
HepatologyGastroenterology
2018English

Evaluation of the Role of Fecal Microbiota Transplantation in the Management of Ulcerative Colitis in Egyptian Patients

Al-Azhar International Medical Journal
2020English

A Randomised Placebo Controlled Trial of Pegylated Interferon in Active Ulcerative Colitis

Gut
Gastroenterology
2003English

Correlation of Fecal Markers With Magnifying Endoscopic Stratification in Patients With Ulcerative Colitis Who Are in Clinical Remission

Digestion
Gastroenterology
2018English

Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2020English

Differential Expression of MUC12, MUC16, and MUC20 in Patients With Active and Remission Ulcerative Colitis

Mediators of Inflammation
ImmunologyCell Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy